Amyris Inc
F:3A01
Amyris Inc
Research & Development
Amyris Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Amyris Inc
F:3A01
|
Research & Development
-$110.2m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
|
Sherwin-Williams Co
NYSE:SHW
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
International Flavors & Fragrances Inc
NYSE:IFF
|
Research & Development
-$694m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-11%
|
|
|
Dupont De Nemours Inc
NYSE:DD
|
Research & Development
-$193m
|
CAGR 3-Years
29%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Ecolab Inc
NYSE:ECL
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
PPG Industries Inc
NYSE:PPG
|
Research & Development
-$423m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
1%
|
|
Amyris Inc
Glance View
Amyris, Inc. engages in the provision of bioscience solutions. The company is headquartered in Emeryville, California and currently employs 980 full-time employees. The company went IPO on 2010-09-28. The firm applies its Lab-to-Market biotechnology platform to engineer, manufacture and market high performance, natural and sustainably sourced products using its computational tools, strain construction tools, screening and analytics tools, and advanced lab automation and data integration. The firm's biotechnology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into high-value ingredients that it manufactures at industrial scale. Through the combination of its biotechnology platform and industrial fermentation process, the Company has developed, produced, and commercialized many distinct molecules. The firm is focused on three market areas, Health & Wellness, Clean Beauty and Flavor & Fragrance. Its brands include Biofene, Hemisqualane, Biossance, clean beauty skincare, Pipette, clean baby skincare and Purecane.
See Also
What is Amyris Inc's Research & Development?
Research & Development
-110.2m
USD
Based on the financial report for Dec 31, 2022, Amyris Inc's Research & Development amounts to -110.2m USD.
What is Amyris Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-14%
Over the last year, the Research & Development growth was -17%. The average annual Research & Development growth rates for Amyris Inc have been -16% over the past three years , -14% over the past five years .
